All Access Articles |
- Analyzing ROIV's Recent Surge – Is the Moon in Sight? | 2025-07-09 | PHARMACEUTICAL
- Unveiling Roivant Sciences (ROIV) as a Defensive Stock per the Graham Test | 2025-06-29 | PHARMACEUTICAL
- Roivant Sciences Reports Financial Results – Revenue Decline & R&D Expense Surge | 2025-05-29 |
- Uncover Roivant Sciences (ROIV) – A Secure Investment Opportunity | 2025-05-28 | PHARMACEUTICAL
- Roivant Sciences Releases 10-Q Report | 2025-02-10 | PHARMACEUTICAL
- Exploring the Potential of Roivant Sciences (ROIV) Stock | 2025-01-04 | PHARMACEUTICAL
- Organon acquires Dermavant for $1.2 billion | 2024-09-18 | PHARMACEUTICAL
- Getting to Know the Facts About Roivant Sciences | 2024-06-23 | PHARMACEUTICAL
- Roivant Sciences Reports Strong Revenue Growth | 2024-05-31 | PHARMACEUTICAL
- Unveiling Roivant Sciences – A Rapid Company Overview | 2024-03-27 | PHARMACEUTICAL
- Key Insights into Roivant Sciences – A Stock Analysis | 2024-03-07 | PHARMACEUTICAL
- Will Roivant Sciences (ROIV) Keep Its Momentum? | 2024-01-06 | PHARMACEUTICAL
- Why Are People Talking About Investing in ROIV? | 2023-09-29 | PHARMACEUTICAL
- Roivant Sciences Investors Should Focus on This | 2023-04-04 | PHARMACEUTICAL
- The Market Is Betting Big on Roivant Sciences (ROIV) - What's the Catch? | 2022-12-27 | BIOTECHNOLOGY